Immunovant Inc (NASDAQ: IMVT) kicked off on Monday, up 3.77% from the previous trading day, before settling in for the closing price of $14.85. Over the past 52 weeks, IMVT has traded in a range of $12.72-$34.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -4.82%. With a float of $68.57 million, this company’s outstanding shares have now reached $170.11 million.
Let’s determine the extent of company efficiency that accounts for 362 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is -258093.12%.
Immunovant Inc (IMVT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Immunovant Inc is 59.89%, while institutional ownership is 55.66%. The most recent insider transaction that took place on May 21 ’25, was worth 318,047. Before that another transaction happened on May 19 ’25, when Company’s Former Director proposed sale 28,188 for $14.58, making the entire transaction worth $410,908.
Immunovant Inc (IMVT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.56% during the next five years compared to -12.18% drop over the previous five years of trading.
Immunovant Inc (NASDAQ: IMVT) Trading Performance Indicators
Take a look at Immunovant Inc’s (IMVT) current performance indicators. Last quarter, stock had a quick ratio of 11.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.74, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -2.87 in one year’s time.
Technical Analysis of Immunovant Inc (IMVT)
Looking closely at Immunovant Inc (NASDAQ: IMVT), its last 5-days average volume was 1.36 million, which is a drop from its year-to-date volume of 1.55 million. As of the previous 9 days, the stock’s Stochastic %D was 82.52%. Additionally, its Average True Range was 0.86.
During the past 100 days, Immunovant Inc’s (IMVT) raw stochastic average was set at 20.87%, which indicates a significant decrease from 95.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.56% in the past 14 days, which was lower than the 63.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.29, while its 200-day Moving Average is $23.53. However, in the short run, Immunovant Inc’s stock first resistance to watch stands at $15.74. Second resistance stands at $16.07. The third major resistance level sits at $16.65. If the price goes on to break the first support level at $14.83, it is likely to go to the next support level at $14.25. Now, if the price goes above the second support level, the third support stands at $13.92.
Immunovant Inc (NASDAQ: IMVT) Key Stats
The company with the Market Capitalisation of 2.63 billion has total of 169,861K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -413,840 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -111,120 K.
